JN's one of the fastest growing biomedical company invested US$ 25 million manufacture and research facility, which has two dedicated buildings for bacterial and neurological disease vaccines production. it has hi-tech production lines for vaccines with a media preparation capacity in fermentors ranging from 30 to 1000 liters. The availability of state-of-the-art fermentors and clean rooms, in combination with efficient, integrated up-/downstream processing operations and automation makes the new unit a landmark in meningococcal bacterial vaccine or neurological vaccine manufacturing in the United States of America.
Services of other enterprises
Contact the seller
Vaccine Manufacture Facilities
View also services categories "Medical Transportation Services"